{
  "retracted": false,
  "timestamp": 1541030400000,
  "updates": [
    {
      "timestamp": 1585017904311,
      "identifier": {
        "doi": "10.1016/j.intimp.2018.08.039"
      },
      "type": "erratum"
    }
  ],
  "identifier": {
    "doi": "10.1016/j.intimp.2018.06.020"
  },
  "publisher": "Elsevier BV",
  "title": "Corrigendum to “Efficacy and safety of biologics targeting IL-17 and IL-23 in the treatment of moderate-to-severe plaque psoriasis: A systematic review and meta-analysis of randomized controlled trials” [Int. Immunopharmacol. 62 (2018) 46–58]"
}
